Published in Infection on September 20, 2007
Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol (2011) 1.18
The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J Clin Microbiol (2010) 1.01
Levels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida species. BMC Infect Dis (2010) 0.91
Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing. Clin Infect Dis (2015) 0.88
Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal Meningitis. Open Forum Infect Dis (2014) 0.86
Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan: a bivariate meta-analysis and systematic review. J Thorac Dis (2015) 0.85
Overcoming antifungal resistance. Drug Discov Today Technol (2014) 0.85
Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse. Exp Biol Med (Maywood) (2009) 0.82
Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts? Ther Clin Risk Manag (2008) 0.79
Fungal infections: their diagnosis and treatment in transplant recipients. Int J Hepatol (2012) 0.79
The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases: A Meta-Analysis of Prospective Cohort Studies. PLoS One (2015) 0.77
Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation. J Clin Microbiol (2014) 0.77
Non-Invasive Methods to Diagnose Fungal Infections in Pediatric Patients with Hematologic Disorders. Jundishapur J Microbiol (2016) 0.75
Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients. Int J Mol Sci (2017) 0.75
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med (1996) 13.49
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet (2000) 4.60
Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc (1996) 4.33
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology (2000) 3.42
Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet (1985) 3.42
Calculation of child and adult standard liver volume for liver transplantation. Hepatology (1995) 3.33
Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology (1997) 3.28
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
Contrast-enhanced ultrasonography during liver surgery. Br J Surg (2004) 2.71
Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol (1991) 2.71
A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol (2000) 2.70
Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. Gene (2001) 2.67
Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest (1993) 2.64
The predictive ability of non-invasive haemodynamic parameters for hypotension during caesarean section: a prospective observational study. Anaesthesia (2015) 2.60
No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg (1999) 2.47
Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery (1994) 2.45
CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins. Blood (1997) 2.37
New retraction technique to allow better visualization of Calot's triangle during laparoscopic cholecystectomy. Surg Endosc (1998) 2.35
Fluorescent cholangiography illuminating the biliary tree during laparoscopic cholecystectomy. Br J Surg (2010) 2.30
Recurrence of hepatocellular carcinoma after surgery. Br J Surg (1996) 2.27
Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg (2001) 2.25
Are left-sided gallbladders really located on the left side? Ann Surg (1997) 2.24
Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg (1999) 2.24
Fractal analysis of cerebral blood flow distribution in Alzheimer's disease. J Nucl Med (2001) 2.08
Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation. Genes Cells (2000) 2.05
Criteria for safe hepatic resection. Am J Surg (1995) 2.03
Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut (2005) 2.03
How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy? Surgery (1995) 2.02
Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group. Ann Intern Med (1998) 2.01
Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg (2000) 1.99
Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet (1987) 1.98
Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology (1998) 1.97
Assessment of vasoactive agents and vascular aging by the second derivative of photoplethysmogram waveform. Hypertension (1998) 1.96
Synaptic plasticity in a cerebellum-like structure depends on temporal order. Nature (1997) 1.94
E-cadherin mediated adhesion system in cancer cells. Cancer (1996) 1.94
Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem (2000) 1.86
A new technique for laparoscopic resection of a submucosal tumor on the posterior wall of the gastric fundus. Surg Endosc (1999) 1.80
A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem (1984) 1.79
Endoscopic diagnosis and treatment of early colorectal cancer. World J Surg (1997) 1.77
Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet (1990) 1.75
Human PEX19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly. Proc Natl Acad Sci U S A (1999) 1.75
Structure of rhodotorucine A, a novel lipopeptide, inducing mating tube formation in Rhodosporidium toruloides. Biochem Biophys Res Commun (1978) 1.74
Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology (1999) 1.73
Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology (1987) 1.73
Living related liver transplantation in adults. Ann Surg (1998) 1.72
Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol (2000) 1.71
Preoperative portal vein embolization: an audit of 84 patients. Hepatology (1999) 1.64
Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine (2000) 1.63
Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology (1993) 1.62
Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Methods (1997) 1.62
Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine (1990) 1.62
E-cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res (1994) 1.61
Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer (1987) 1.60
Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg (1989) 1.59
Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg (2001) 1.58
Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer (1990) 1.58
Measurement of cerebral hemodynamics with perfusion-weighted MR imaging: comparison with pre- and post-acetazolamide 133Xe-SPECT in occlusive carotid disease. AJNR Am J Neuroradiol (2001) 1.54
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut (2005) 1.54
Gangliocytic paraganglioma of the papilla of Vater with regional lymph node metastasis. Am J Gastroenterol (1992) 1.52
"Giant" colon lipoma: what kind of findings are necessary for the indication of endoscopic resection? Am J Gastroenterol (2001) 1.51
Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury. Gene Ther (1999) 1.51
Congestion of right liver graft in living donor liver transplantation. Transplantation (2001) 1.51
Computerized classification of interstitial lung abnormalities on chest radiographs with normalized radiographic index and normalized fractal dimension. Eur J Radiol (2001) 1.51
Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res (2001) 1.50
Serous cystadenoma of the pancreas with invasive growth: benign or malignant? Am J Gastroenterol (1998) 1.49
Inflammatory pseudotumors of the liver: prevalence and clinical impact in surgical patients. Hepatogastroenterology (2001) 1.49
The use of operative ultrasound as an aid to liver resection in patients with hepatocellular carcinoma. World J Surg (1987) 1.49
The problem of de novo colorectal carcinoma. Eur J Cancer (1995) 1.49
Beta-catenin expression in human cancers. Am J Pathol (1996) 1.47
Successful living-related partial liver transplantation to an adult patient. Lancet (1994) 1.47
Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial. Br J Cancer (2001) 1.47
Arterial ketone body ratio in liver surgery. Hepatology (1994) 1.45
The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. AJR Am J Roentgenol (1990) 1.45
Regulation of the TAK1 signaling pathway by protein phosphatase 2C. J Biol Chem (2000) 1.44
Establishment of a cell line of human endometrial adenocarcinoma in vitro. Am J Obstet Gynecol (1972) 1.44
Cryptococcosis after living donor liver transplantation: report of three cases. Transpl Infect Dis (2005) 1.44
Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder. Hum Pathol (2001) 1.43
Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene (2006) 1.43
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest (1999) 1.42
Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg (1999) 1.42
The peroxin Pex14p. cDNA cloning by functional complementation on a Chinese hamster ovary cell mutant, characterization, and functional analysis. J Biol Chem (1999) 1.41
High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology (1996) 1.41
Resection for multiple metastatic liver tumors after portal embolization. Surgery (1994) 1.41
Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer. Virchows Arch (1994) 1.40
Risk factors for acute rejection in pediatric living related liver transplantation: the impact of HLA matching. Liver Transpl (2001) 1.40
A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer (2001) 1.40
Prognosis in gastric cancer associated with pregnancy. World J Surg (1991) 1.39
Staged coronary artery bypass grafting after percutaneous angioplasty for intracranial vascular stenosis. J Thorac Cardiovasc Surg (2001) 1.38
An evaluation of the accelerated expectation maximization algorithms for single-photon emission tomography image reconstruction. Eur J Nucl Med (1994) 1.38
Healing process of sutureless choledochojejunostomy in an experimental model. Br J Surg (1995) 1.37
Preoperative measurement of segmental liver volume of donors for living related liver transplantation. Hepatology (1993) 1.36
Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma. J Hepatol (1997) 1.36
Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases. Cancer Res (1988) 1.36
Anastomotic aneurysms after surgical treatment of Takayasu's arteritis: a 40-year experience. J Vasc Surg (1998) 1.35
Relation among portal segmentation, proper hepatic vein, and external notch of the caudate lobe in the human liver. Ann Surg (2000) 1.35